{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30250104", "DateCompleted": {"Year": "2019", "Month": "10", "Day": "29"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "24"}], "Language": ["eng"], "ELocationID": ["14280", "10.1038/s41598-018-32651-4"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "8", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Sep", "Day": "24"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis.", "Pagination": {"StartPage": "14280", "MedlinePgn": "14280"}, "Abstract": {"AbstractText": ["Most clinical studies of Cannabis today focus on the contents of two phytocannabinoids: (-)-\u0394<sup>9</sup>-trans-tetrahydrocannabinol (\u0394<sup>9</sup>-THC) and cannabidiol (CBD), regardless of the fact that the plant contains over 100 additional phytocannabinoids whose therapeutic effects and interplay have not yet been fully elucidated. This narrow view of a complex Cannabis plant is insufficient to comprehend the medicinal and pharmacological effects of the whole plant. In this study we suggest a new ESI-LC/MS/MS approach to identify phytocannabinoids from 10 different subclasses, and comprehensively profile the identified compounds in diverse medical Cannabis plants. Overall, 94 phytocannabinoids were identified and used for profiling 36 of the most commonly used Cannabis plants prescribed to patients in Israel. In order to demonstrate the importance of comprehensive phytocannabinoid analysis before and throughout medical Cannabis clinical trials, treatments, or experiments, we evaluated the anticonvulsant effects of several equally high-CBD Cannabis extracts (50% w/w). We found that despite the similarity in CBD contents, not all Cannabis extracts produced the same effects. This study's approach for phytocannabinoid profiling can enable researchers and physicians to analyze the effects of specific Cannabis compositions and is therefore critical when performing biological, medical and pharmacological-based research using Cannabis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}], "LastName": "Berman", "ForeName": "Paula", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}], "LastName": "Futoran", "ForeName": "Kate", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}], "LastName": "Lewitus", "ForeName": "Gil M", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}], "LastName": "Mukha", "ForeName": "Dzmitry", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}], "LastName": "Benami", "ForeName": "Maya", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}, {"Identifier": [], "Affiliation": "Department of Computer Science, Technion-Israel Institute of Technology, Haifa, 3200003, Israel."}], "LastName": "Shlomi", "ForeName": "Tomer", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel. dmeiri@technion.ac.il."}], "LastName": "Meiri", "ForeName": "David", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cannabinoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Hallucinogens"}, {"RegistryNumber": "0", "NameOfSubstance": "Medical Marijuana"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "19GBJ60SN5", "NameOfSubstance": "Cannabidiol"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Cannabidiol"}, {"QualifierName": ["chemistry", "genetics"], "DescriptorName": "Cannabinoids"}, {"QualifierName": ["chemistry", "genetics"], "DescriptorName": "Cannabis"}, {"QualifierName": [], "DescriptorName": "Chromatography, Liquid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hallucinogens"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Medical Marijuana"}, {"QualifierName": ["genetics"], "DescriptorName": "Metabolome"}, {"QualifierName": [], "DescriptorName": "Metabolomics"}, {"QualifierName": ["chemistry", "genetics"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Tandem Mass Spectrometry"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "ElSohly MA, Slade D. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 2005;78:539\u2013548. doi: 10.1016/j.lfs.2005.09.011.", "ArticleIdList": ["10.1016/j.lfs.2005.09.011", "16199061"]}, {"Citation": "Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin. Neurosci. 2007;9:413\u2013430.", "ArticleIdList": ["PMC3202504", "18286801"]}, {"Citation": "Lukhele ST, Motadi LR. Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells. BMC Complement. Altern. Med. 2016;16:335. doi: 10.1186/s12906-016-1280-0.", "ArticleIdList": ["10.1186/s12906-016-1280-0", "PMC5009497", "27586579"]}, {"Citation": "Deng L, Ng L, Ozawa T, Stella N. Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture. J. Pharmacol. Exp. Ther. 2017;360:215\u2013224. doi: 10.1124/jpet.116.236968.", "ArticleIdList": ["10.1124/jpet.116.236968", "PMC5193074", "27821713"]}, {"Citation": "Dana N, et al. Cannabis sativa extract reduces cytoskeletal associated proteins in breast cancer cell line. Int. J. Cancer. Manag. 2017;10:e5474. doi: 10.5812/ijcm.5474.", "ArticleIdList": ["10.5812/ijcm.5474"]}, {"Citation": "Watt G, Karl T. In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer\u2019s disease. Front. Pharmacol. 2017;8:20. doi: 10.3389/fphar.2017.00020.", "ArticleIdList": ["10.3389/fphar.2017.00020", "PMC5289988", "28217094"]}, {"Citation": "Tzadok M, et al. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience. Seizure. 2016;35:41\u201344. doi: 10.1016/j.seizure.2016.01.004.", "ArticleIdList": ["10.1016/j.seizure.2016.01.004", "26800377"]}, {"Citation": "Crippa JA, Crippa AC, Hallak JE, Mart\u00edn-Santos R, Zuardi AW. \u03949-THC intoxication by cannabidiol-enriched Cannabis extract in two children with refractory epilepsy: Full remission after switching to purified cannabidiol. Front. Pharmacol. 2016;7:359. doi: 10.3389/fphar.2016.00359.", "ArticleIdList": ["10.3389/fphar.2016.00359", "PMC5043219", "27746737"]}, {"Citation": "Holgado MA, Mart\u00edn-Banderas L, \u00c1lvarez-Fuentes J, Fern\u00e1ndez-Ar\u00e9valo M. Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases. J. Drug Deliv. Sci. Technol. 2017;42:84\u201393. doi: 10.1016/j.jddst.2017.04.023.", "ArticleIdList": ["10.1016/j.jddst.2017.04.023"]}, {"Citation": "Mannucci C, et al. Neurological aspects of medical use of cannabidiol. CNS Neurol. Disord. Drug Targets. 2017;16:541\u2013553. doi: 10.2174/1871527316666170413114210.", "ArticleIdList": ["10.2174/1871527316666170413114210", "28412918"]}, {"Citation": "Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65:812\u2013819. doi: 10.1212/01.wnl.0000176753.45410.8b.", "ArticleIdList": ["10.1212/01.wnl.0000176753.45410.8b", "16186518"]}, {"Citation": "Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bronner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561\u2013564. doi: 10.1038/346561a0.", "ArticleIdList": ["10.1038/346561a0", "2165569"]}, {"Citation": "Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014;5:5852\u20135872. doi: 10.18632/oncotarget.2233.", "ArticleIdList": ["10.18632/oncotarget.2233", "PMC4171598", "25115386"]}, {"Citation": "Alexander SPH, Mathie A, Peters JA. G Protein\u2010coupled receptors. Br. J. Pharmacol. 2011;164:5\u2013113. doi: 10.1111/j.1476-5381.2011.01649_1.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01649_1.x", "0"]}, {"Citation": "Ross RA. Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 2003;140:790\u2013801. doi: 10.1038/sj.bjp.0705467.", "ArticleIdList": ["10.1038/sj.bjp.0705467", "PMC1574087", "14517174"]}, {"Citation": "Dobovi\u0161ek L, Hojnik M, Ferk P. Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review) Int. J. Mol. Med. 2016;38:1642\u20131651. doi: 10.3892/ijmm.2016.2779.", "ArticleIdList": ["10.3892/ijmm.2016.2779", "27779654"]}, {"Citation": "Turner, S. E., Williams, C. M., Iversen, L. & Whalley, B. J. Molecular pharmacology of phytocannabinoids in Phytocannabinoids (eds. Kinghorn A. D. Falk H. Gibbons S. & Kobayashi J.) 61\u2013101 (Springer International Publishing, Switzerland 2017).", "ArticleIdList": ["28120231"]}, {"Citation": "Morales, P., Hurst, D. P. & Reggio, P. H. Molecular targets of the phytocannabinoids: A complex picture in Phytocannabinoids (eds Kinghorn A. D. Falk H. Gibbons S. & Kobayashi J.) 103\u2013131 (Springer International Publishing, Switzerland 2017).", "ArticleIdList": ["PMC5345356", "28120232"]}, {"Citation": "Hanu\u0161 LO, Meyer SM, Mu\u00f1oz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat. Prod. Rep. 2016;33:1357\u20131392. doi: 10.1039/C6NP00074F.", "ArticleIdList": ["10.1039/C6NP00074F", "27722705"]}, {"Citation": "ElSohly Mahmoud A., Gul Waseem. Handbook of Cannabis. 2014. Constituents of Cannabis Sativa; pp. 3\u201322."}, {"Citation": "Flores-Sanchez IJ, Verpoorte R. Secondary metabolism in Cannabis. Phytochem. Rev. 2008;7:615\u2013639. doi: 10.1007/s11101-008-9094-4.", "ArticleIdList": ["10.1007/s11101-008-9094-4"]}, {"Citation": "Appendino G, Chianese G, Taglialatela-Scafati O. Cannabinoids: occurrence and medicinal chemistry. Curr. Med. Chem. 2011;18:1085\u20131099. doi: 10.2174/092986711794940888.", "ArticleIdList": ["10.2174/092986711794940888", "21254969"]}, {"Citation": "Shani A, Mechoulam R. Cannabielsoic acids: Isolation and synthesis by a novel oxidative cyclization. Tetrahedron. 1974;30:2437\u20132446. doi: 10.1016/S0040-4020(01)97114-5.", "ArticleIdList": ["10.1016/S0040-4020(01)97114-5"]}, {"Citation": "Crombie L, Ponsford R, Shani A, Yagnitinsky B, Mechoulam R. Hashish components. Photochemical production of cannabicyclol from cannabichromene. Tetrahedron Lett. 1968;9:5771\u20135772. doi: 10.1016/S0040-4039(00)76346-5.", "ArticleIdList": ["10.1016/S0040-4039(00)76346-5", "5697175"]}, {"Citation": "Shoyama Y, Oku R, Yamauchi T, Nishioka I. Cannabis. VI. Cannabicyclolic acid. Chem. Pharm. Bull. 1972;20:1927\u20131930. doi: 10.1248/cpb.20.1927.", "ArticleIdList": ["10.1248/cpb.20.1927"]}, {"Citation": "Brenneisen, R. Chemistry and analysis of phytocannabinoids and other Cannabis constituents in Marijuana and the Cannabinoids (ed. ElSohly, M. A.) 17\u201349 (Humana Press, Totowa, New Jersey, 2007)."}, {"Citation": "Turner CE, Elsohly MA. Constituents of Cannabis sativa L. XVI. A possible decomposition pathway of \u03949\u2010tetrahydrocannabinol to cannabinol. J. Heterocycl. Chem. 1979;16:1667\u20131668. doi: 10.1002/jhet.5570160834.", "ArticleIdList": ["10.1002/jhet.5570160834"]}, {"Citation": "Carbone M, et al. Chemical characterisation of oxidative degradation products of \u03949-THC. Tetrahedron. 2010;66:9497\u20139501. doi: 10.1016/j.tet.2010.10.025.", "ArticleIdList": ["10.1016/j.tet.2010.10.025"]}, {"Citation": "Keller A, Leupin M, Mediavilla V, Wintermantel E. Influence of the growth stage of industrial hemp on chemical and physical properties of the fibres. Ind. Crop. Prod. 2001;13:35\u201348. doi: 10.1016/S0926-6690(00)00051-0.", "ArticleIdList": ["10.1016/S0926-6690(00)00051-0"]}, {"Citation": "Raharjo TJ, Verpoorte R. Methods for the analysis of cannabinoids in biological materials: a review. Phytochem. Anal. 2004;15:79\u201394. doi: 10.1002/pca.753.", "ArticleIdList": ["10.1002/pca.753", "15116938"]}, {"Citation": "Hazekamp A, Peltenburg A, Verpoorte R, Giroud C. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa L. J. Liq. Chromatogr. Relat. Technol. 2005;28:2361\u20132382. doi: 10.1080/10826070500187558.", "ArticleIdList": ["10.1080/10826070500187558"]}, {"Citation": "De Backer B, et al. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J. Chromatogr. B. 2009;877:4115\u20134124. doi: 10.1016/j.jchromb.2009.11.004.", "ArticleIdList": ["10.1016/j.jchromb.2009.11.004", "19932642"]}, {"Citation": "Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry. 2010;71:2058\u20132073. doi: 10.1016/j.phytochem.2010.10.001.", "ArticleIdList": ["10.1016/j.phytochem.2010.10.001", "21040939"]}, {"Citation": "Peschel W, Politi M. 1H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. Talanta. 2015;140:150\u2013165. doi: 10.1016/j.talanta.2015.02.040.", "ArticleIdList": ["10.1016/j.talanta.2015.02.040", "26048837"]}, {"Citation": "Giese MW, Lewis MA, Giese L, Smith KM. Method for the analysis of cannabinoids and terpenes in Cannabis. J. AOAC Int. 2015;98:1503\u20131522. doi: 10.5740/jaoacint.15-116.", "ArticleIdList": ["10.5740/jaoacint.15-116", "26651562"]}, {"Citation": "Hazekamp A, Tejkalov\u00e1 K, Papadimitriou S. Cannabis: from cultivar to chemovar II\u2014a metabolomics approach to Cannabis classification. Cannabis Cannabinoid Res. 2016;1:202\u2013215. doi: 10.1089/can.2016.0017.", "ArticleIdList": ["10.1089/can.2016.0017"]}, {"Citation": "Aizpurua-Olaizola O, et al. Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. J. Nat. Prod. 2016;79:324\u2013331. doi: 10.1021/acs.jnatprod.5b00949.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00949", "26836472"]}, {"Citation": "Vergara D, et al. Compromised external validity: Federally produced Cannabis does not reflect legal markets. Sci. Rep. 2017;7:46528. doi: 10.1038/srep46528.", "ArticleIdList": ["10.1038/srep46528", "PMC5395929", "28422145"]}, {"Citation": "Thomas BF, Compton DR, Martin BR. Characterization of the lipophilicity of natural and synthetic analogs of \u03949-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther. 1990;255:624\u2013630.", "ArticleIdList": ["2173751"]}, {"Citation": "Vree TB. Mass spectrometry of cannabinoids. J. Pharm. Sci. 1977;66:1444\u20131450. doi: 10.1002/jps.2600661025.", "ArticleIdList": ["10.1002/jps.2600661025", "925901"]}, {"Citation": "Harvey DJ. Mass spectrometry of the cannabinoids and their metabolites. Mass Spectrom. Rev. 1987;6:135\u2013229. doi: 10.1002/mas.1280060104.", "ArticleIdList": ["10.1002/mas.1280060104"]}, {"Citation": "Kajima M, Piraux M. The biogenesis of cannabinoids in Cannabis sativa. Phytochemistry. 1982;21:67\u201369. doi: 10.1016/0031-9422(82)80016-2.", "ArticleIdList": ["10.1016/0031-9422(82)80016-2"]}, {"Citation": "Shoyama Y, Hirano H, Nishioka I. Biosynthesis of propyl cannabinoid acid and its biosynthetic relationship with pentyl and methyl cannabinoid acids. Phytochemistry. 1984;23:1909\u20131912. doi: 10.1016/S0031-9422(00)84939-0.", "ArticleIdList": ["10.1016/S0031-9422(00)84939-0"]}, {"Citation": "Flores-Sanchez IJ, Linthorst HJ, Verpoorte R. In silicio expression analysis of PKS genes isolated from Cannabis sativa L. Genet. Mol. Biol. 2010;33:633\u2013636. doi: 10.1590/S1415-47572010005000088.", "ArticleIdList": ["10.1590/S1415-47572010005000088", "PMC3036156", "21637580"]}, {"Citation": "Sumner LW, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. 2007;3:211\u2013221. doi: 10.1007/s11306-007-0082-2.", "ArticleIdList": ["10.1007/s11306-007-0082-2", "PMC3772505", "24039616"]}, {"Citation": "Santos RG, Hallak JE, Leite JP, Zuardi AW, Crippa JA. Phytocannabinoids and epilepsy. J. Clin. Pharm. Ther. 2015;40:135\u2013143. doi: 10.1111/jcpt.12235.", "ArticleIdList": ["10.1111/jcpt.12235", "25475762"]}, {"Citation": "Number of Legal Medical Marijuana Patients. http://medicalmarijuana.procon.org/ (2018)."}, {"Citation": "Russo EB, Taming THC. potential cannabis synergy and phytocannabinoid-terpenoid entourage effects: Phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 2011;163:1344\u20131364. doi: 10.1111/j.1476-5381.2011.01238.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238.x", "PMC3165946", "21749363"]}, {"Citation": "Sanchez-Ramos J. The entourage effect of the phytocannabinoids. Ann. Neurol. 2015;77:1083. doi: 10.1002/ana.24402.", "ArticleIdList": ["10.1002/ana.24402", "25754306"]}, {"Citation": "Annesley TM. Ion suppression in mass spectrometry. Clin. Chem. 2003;49:1041\u20131044. doi: 10.1373/49.7.1041.", "ArticleIdList": ["10.1373/49.7.1041", "12816898"]}, {"Citation": "Furey A, Moriarty M, Bane V, Kinsella B, Lehane M. Ion suppression; a critical review on causes, evaluation, prevention and applications. Talanta. 2013;115:104\u2013122. doi: 10.1016/j.talanta.2013.03.048.", "ArticleIdList": ["10.1016/j.talanta.2013.03.048", "24054567"]}, {"Citation": "Hazekamp, A. Cannabis; extracting the medicine. Department of Pharmacognosy (IBL), Faculty of Science, Leiden University (2007)."}, {"Citation": "Jones NA, et al. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. J. Pharmacol. Exp. Ther. 2010;332:569\u2013577. doi: 10.1124/jpet.109.159145.", "ArticleIdList": ["10.1124/jpet.109.159145", "PMC2819831", "19906779"]}, {"Citation": "Klein BD, et al. Evaluation of cannabidiol in animal seizure models by the epilepsy therapy screening program (ETSP) Neurochem. Res. 2017;42:1939\u20131948. doi: 10.1007/s11064-017-2287-8.", "ArticleIdList": ["10.1007/s11064-017-2287-8", "28478594"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "9"}, {"Year": "2018", "Month": "9", "Day": "3"}, {"Year": "2018", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["30250104", "PMC6155167", "10.1038/s41598-018-32651-4", "10.1038/s41598-018-32651-4"]}}]}